Researchers at McMaster University are leading preclinical studies into a novel drug candidate developed by Espervita ...
Residual CFTR function in cystic fibrosis was associated with better glucose tolerance and insulin secretion, with CFTR ...
A new drug combination shows unexpected synergy against liver fibrosis. A new study reveals that using two drugs together ...
Tony Arenas of Sussex, who inspired many with his positive outlook, died at age 41. Arenas battled cystic fibrosis his entire life and was later diagnosed with stage 4 colon cancer. He and his family ...
Please provide your email address to receive an email when new articles are posted on . Chronic respiratory therapies included inhaled antibiotics, hypertonic saline, dornase alfa and oral ...
Cystic fibrosis carriers face a significantly higher risk for secondary pneumonia following influenza infection compared with noncarriers, a finding that may have a substantial impact on the US ...
The U.S. Food and Drug Administration (FDA) has approved Jascayd (nerandomilast), taken as oral tablets, as a treatment for adults with progressive pulmonary fibrosis (PPF), in which lung scarring ...
In a registry-based study, pulmonary exacerbations (PEx) affected nearly one third of children with cystic fibrosis in the first 3 years of life and were linked to lower lung function at age 6 and ...
What Is Jascayd, and Why Does It Matter? Jascayd (nerandomilast) is now approved for treating adults with progressive pulmonary fibrosis (PPF) that causes gradual and permanent scarring in the lungs, ...
KJ Muldoon received a groundbreaking new treatment earlier this year. The baby saved from a rare disease by a first-ever personalized gene fix has reached a big milestone, taking his first steps ahead ...
Growing up, I fiddled with many different instruments … piano, guitar, even cello for a few days. However, there was only one instrument that really stuck with me: the bagpipes. I started playing in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results